Isabel Hurtado-Gomez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis.
Journal: Hepatology communications
Published: November 08, 2025
Antagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 19, 2025
LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptor.
Journal: JHEP reports : innovation in hepatology
Published: January 19, 2025
Aging Deteriorates Blood Brain Barrier Function and Polarizes Adaptive T Cell Expansion Contributing to Neurocognitive Damage in Experimental Cirrhosis.
Journal: Aging and disease
Published: August 02, 2024
Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 18, 2023
The 3Rs in Experimental Liver Disease.
Journal: Animals : an open access journal from MDPI
Published: June 14, 2023
Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance.
Journal: JHEP reports : innovation in hepatology
Published: July 07, 2022
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.
Journal: International journal of environmental research and public health
Published: March 23, 2021
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 27, 2020
Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short-Chain Fatty Acids in Experimental Cirrhosis.
Journal: Hepatology communications
Published: July 05, 2018
AIM2 deficiency reduces the development of hepatocellular carcinoma in mice.
Journal: International journal of cancer
Published: March 06, 2018
Last Updated: 09/26/2026